These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27761030)

  • 1. Routine Treatment of Cervical Cytological Cell Changes: Diagnostic Standard, Prevention and Routine Treatment of Cervical Cytological Cell Changes - An Assessment of Primary and Secondary Prevention and Routine Treatment Data in the Context of an Anonymous Data Collection from Practicing Gynaecologists; an Academic, Non-Interventional Study.
    Huber J; Pötsch B; Gantschacher M; Templ M
    Geburtshilfe Frauenheilkd; 2016 Oct; 76(10):1086-1091. PubMed ID: 27761030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of suspicious and doubtful cytological findings in gynecologic serial examinations].
    Goldmann C; Herold E; Neuser D; Sielaff E
    Zentralbl Gynakol; 1978; 100(1):17-22. PubMed ID: 645278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic verification of Group III and III D cytological tests with special reference to follow-up].
    Schlegel H; Kühndel K
    Zentralbl Gynakol; 1983; 105(24):1585-96. PubMed ID: 6666444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological finding in the pre- and early stages of cervix carcinoma--a contribution to the evaluation of Papanicolau III].
    Bader G; Büttner HH; Neumann HG; Rhode E; Beust M
    Zentralbl Gynakol; 1977; 99(11):657-60. PubMed ID: 899349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAP smear after radiation therapy for cervical carcinoma.
    Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
    Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytological and histological parallels in atypical colposcopic findings].
    Raĭcheva I; Lazarova L; Zlatkov V; Maĭnkhard K; Raĭcheva S; Zamfirova K
    Akush Ginekol (Sofiia); 1998; 37(2):23-5. PubMed ID: 9859530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Papillomaviruses and herpesviruses as selected risk factors in the etiopathogenesis of cervix neck cancer. I. Use of nucleic acid hybridization for diagnosing HPV infections].
    Szkoda MT; Rekosz M; Litwińska B; Kańtoch M
    Med Dosw Mikrobiol; 1999; 51(3-4):383-92. PubMed ID: 10803268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of cytological routine checks (author's transl)].
    Scholz A
    Zentralbl Gynakol; 1979; 101(15):958-61. PubMed ID: 532421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follow-up not according to guidelines after an abnormal cervix smear].
    Kreuger FA; Beerman H; Nijs HG; Wijnen JA
    Ned Tijdschr Geneeskd; 1996 Apr; 140(15):833-6. PubMed ID: 8668277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
    Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
    Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytological screening--the technique of cytological specimen taking and its influence on the quality of the method].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(8):26-7. PubMed ID: 18642552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positive cytological smears in adolescents and young women].
    Steps H
    Geburtshilfe Frauenheilkd; 1982 Aug; 42(8):613-5. PubMed ID: 6922814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.